Innate immune response to viral infection of the lungs

Paediatric Respiratory Reviews

Volumn 9, Issue 4, 2008, Pages 243-250

  See, Hayley ^a   Wark, Peter ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

influenza; innate immune response; respiratory viral infection; rhinovirus; Toll like receptor; type 1 interferon

Indexed keywords

CYTOKINE; INTERFERON; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ASTHMA; CELL FUNCTION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE PREDISPOSITION; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHINOVIRUS; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS IMMUNITY; VIRUS INFECTION;

DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; LUNG DISEASES; MACROPHAGES, ALVEOLAR; RESPIRATORY MUCOSA; VIRUS DISEASES;

EID: 56049088950     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2008.04.001     Document Type: Review

References (74)

1. Heikkinen T., and Jarvinen A. The common cold. Lancet 361 (2003) 51-59
2. Monto A.S., and Sullivan K.M. Acute respiratory illness in the community: frequency of illness and the agents involved. Epidemiol Infect 110 (1993) 145-160
3. Elnifro E.M., Ashshi A.M., Cooper R.J., and Klapper P.E. Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev 13 (2000) 559-570
4. Manoha C., Espinosa S., Aho S., Huet F., and Pothier P. Epidemiological and clinical features of hMPV, RSV and RVs infections in young children. J Clin Virol 38 (2007) 221-226
5. Wang D., Coscoy L., Zylberberg M., et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 99 (2002) 15687-15692
6. Kistler A., Avila P.C., Rouskin S., et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 196 (2007) 817-825
7. Monto A.S. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 16 (1994) 351-373
8. Winther B., Farr B., Turner R., Hendley J.O., Gwaltney J.M., and Mygind N. Histopathological examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Oto Layrngol 413 Suppl (1984) 19-24
9. Turner R.B. The role of neutrophils in the pathogenesis of rhinovirus infections. Pediatr Infect Dis J 9 (1990) 832-835
10. Henderson F.W., Clyde W.A., and Collier A.M. The etiologic and epidemeologic spectrum of bronchiolitis in pediatric practice. J Pediatr 95 (1979) 183-186
11. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., and Walsh E.E. Respiratory syncytial virus infection in elderly and high risk adults. N Engl J Med 352 (2005) 1749-1759
12. Hacking D., and Hull J. Respiratory syncytial virus - viral biology and the host response. J Infect 45 (2002) 18-24
13. Palese P. Influenza: old and new threats. Nat Med 10 (2004) S82-S87
14. Treanor J.J. Influenza A and B viruses. In: Lenfant C. (Ed). Viral Infections of the Respiratory Tract (1999), Marcel Dekker, New York 105-160
15. Johnston S.L., Pattemore P.K., Sanderson G., et al. Community study of the role of viral infections in exacerbations of asthma in 9-11year old children. BMJ 310 (1995) 1225-1228
16. Gern J.E. Rhinovirus respiratory infections and asthma. Am J Med 112 (2002) 19S-27S
17. Grissell T.V., Powell H., Shaffren D.R., et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 172 (2005) 433-439
18. Wark P.A.B., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., and Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19 (2002) 68-75
19. Seemungal T., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1618-1623
20. Schroth M.K., Grimm E., Frindt P., et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 20 (1999) 1220-1228
21. Subauste M.C., Jacoby D.B., Richards S.M., and Proud D. Infection of human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96 (1995) 549-557
22. Staunton D.E., Merluzzi V.J., Rothlein R., Barton R., Marlin S.D., and Springer T.A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56 (1989) 849-853
23. Gern J.E., Vrtis R., Grindle K.A., Swenson C.A., and Busse W. Relationship of upper and lower airway cytokines to outcomes of experimental rhinovirus infection. Am J Respir Crit Care Med 162 (2000) 2226-2231
24. Grunberg K., Sharon R.F., Sont J.K., et al. Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 164 (2001) 1816-1822
25. Gern J.E., Galagan D.M., Jarjour N.N., Dick E.C., and Busse W.W. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155 (1997) 1159-1161
26. Grunberg K., Timmers M.C., de Klerk E.P.A., and Sterk P.J. Experimental rhinovirus 16 infection causes variable airflow obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 160 (1999) 1375-1380
27. Corne J.M., Marshall C., Smith S., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359 (2002) 831-834
28. Khetsuriani N., Kazerouni N., Erdman D.D., et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119 (2007) 314-321
29. Yamamoto M., Sato S., Hemmi H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
30. Edwards M.R., Slater L., and Johnston S.L. Signalling pathways mediating type I interferon gene expression. Microbes Infect 9 (2007) 1245-1251
31. Tabiasco J., Devevre E., Rufer N., et al. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol 177 (2006) 8708-8713
32. Lore K., Betts M.R., Brenchley J.M., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J Immunol 171 (2003) 4320-4328
33. Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., and Schleimer R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 31 (2004) 358-364
34. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
35. Bowie A.G., and Haga I.R. The role of toll like receptors in the host response to viruses. Mol Immunol 42 (2005) 859-867
36. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat Immunol 7 (2006) 131-137
37. Akira S., Uematsu S., and Takeuchi K. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
38. Thompson A.J.V., and Locarnini S.A. Toll-like receptors. RIG-I-like helicases and the antiviral innate immune response. Immunol Cell Biol 10 (2007) 1-11
39. Kato H., Takeuchi O., Sato S., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006) 101-105
40. Katze M.G., He Y., Gale Jr. M., and Viruses. interferon: a fight for supremacy. Nat Rev Immunol 2 (2002) 675-687
41. Sato M., Suemori H., Hata N., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 (2000) 539-548
42. Song M., and Shuai K. The suppressor of cytokine signalling (SOCS) 1 and SOCS3 but not SOCS 2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 273 (1998) 35056-35062
43. Darnell J.E., Kerr I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science 264 (1994) 1415-1421
44. Katze M., He Y., and Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2 (2002) 675-687
45. Mibayashi M., Martinez-Sobrido L., Loo Y.-M., Cardenas W.B., Gale Jr. M., and Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81 (2007) 514-524
46. Knight D.A., and Holgate S.T. The airway epithelium: Structural and functional properties in health and disease. Respirology 8 (2003) 432-446
47. Lopez-Souza N., Dolganov G., Dubin R., et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 286 (2004) L373-L381
48. Bossios A., Psarras S., Gourgiotis D., et al. Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 6 (2005) 114-120
49. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 7 (2003) 710-720
50. Proud D., Sanders S.P., and Wiehler S. Human rhinovirus infection induces airway epithelial cell production of human (beta)-defensin 2 both in vitro and in vivo. J Immunol 172 (2004) 4637-4645
51. Yang D., Chertov O., Bykovskaia S.N., et al. B-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525
52. Kharitonov S., Yates D.H., Robbins R.A., Logan-Sinclair R., Shinebourne E.A., and Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
53. Kharitonov S., Yates D.H., and Barnes P.J. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 8 (1995) 295-297
54. Lane C., Knight D.A., Burgess S., et al. Epithelial inducible nitric oxide synthetase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 196 (2004) 340-344
55. Reiss C.S., and Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol 72 (1998) 4547-4551
56. Sanders S.P., Siekierski E.S., Porter J.D., Richards S.M., and Proud D. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 72 (1998) 934-942
57. Sanders S.P., Kim J., Connolly K.R., Porter J.D., Sierkierski E.S., and Proud D. Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am J Respir Cell Mol Biol 24 (2001) 317-325
58. Carraro S., Doherty J., Zaman K., et al. S-nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. Am J Physiol Lung Cell Mol Physiol 290 (2006) L827-832
59. Hunt J.F., Gaston B., and Ricciardolo F. Acid stress in the pathology of asthma. J Allergy Clin Immunol 113 (2004) 610-619
60. Wark P.A.B., Johnston S.L., Bucchieri F., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005) 937-947
61. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23 (2005) 275-306
62. Zuniga E.I., McGavern D.B., Pruneda-Paz J.L., Teng C., and Oldstone M.B. Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection. Nat Immunol 5 (2004) 1227-1234
63. Kadowaki N., Ho S., Antonenko S., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001) 863-869
64. Jarrossay D., Napolitani G., Colonna M., Sallusto F., and Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol 31 (2001) 3388-3393
65. Siegal F.P., Kadowaki N., Shodell M., et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
66. Kumagai Y., Takeuchi O., Kato H., et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27 (2007) 240-252
67. Tough D.F., Borrow P., and Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272 (1996) 1947-1950
68. + T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur J Immunol 32 (2002) 2807-2816
69. Zhang X., Sun S., Hwang I., Tough D.F., and Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8 (1998) 591-599
70. + T cells provide an early source of IFN-gamma. J Immunol 170 (2003) 2399-2408
71. Tough D.F., and Sprent J. Bystander stimulation of T cells in vivo by cytokines. Vet Immunol Immunopathol 63 (1998) 123-129
72. Yoon H., Legge K.L., Sung S.S., and Braciale T.J. Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol 179 (2007) 391-399
73. + memory T cell subsets via IL-15. J Immunol 178 (2007) 4786-4792
74. Dong Kim K., Zhao J., Auh S., et al. Adaptive immune cells temper initial innate responses. Nat Med 13 (2007) 1248-1252